Synexis - Chapter 11 Case Summary

Synexis, an Overland Park, KS-based developer and supplier of devices that generate dry hydrogen peroxide for continuous pathogen reduction in occupied indoor spaces, filed for Chapter 11 after spending on R&D, intellectual property, regulatory compliance, inventory, and commercial expansion outpaced revenue, leading to a 2026 liquidity squeeze compounded by delays in expected cash sources, including an unpaid Employee Retention Credit. The Company is pursuing a sale, backed by a proposed $1.5 million DIP facility.

Business Description

Headquartered in Overland Park, KS, Synexis, LLC ("Synexis" or the "Company") develops and supplies devices that generate dry hydrogen peroxide ("DHP"), a gaseous form of hydrogen peroxide, for continuous pathogen reduction in occupied indoor spaces. The Company pairs its proprietary devices with replacement filters, catalyst materials, bulbs, and maintenance services, which customers need for as long as the installed equipment remains in use.

The Company's products have more than 8,800 active installations in more than 570 facilities. Its customers are mainly operators of healthcare, education, food-production, commercial, and animal-health facilities.


Corporate History

Synexis was formed as a Delaware limited liability company in 2008 under the name Lee Technology Group LLC. It became Lee Antimicrobial Solutions LLC on June 9, 2008, and took its current name on June 8, 2016. From the start, the Company has focused on commercializing its DHP technology. It brought its original Blade and Sentry devices to market in 2016, followed by the Sphere in 2019 and the Sentry XL in 2024.

Synexis owns a 92.5% interest in one largely inactive subsidiary, Synexis BioDefense LLC, a Delaware limited liability company, and all of the equity of one Canadian subsidiary, Synexis Canada Ltd. The Company's equity consists of Common Units, Series B Units, and preferred units in several Series A classes, governed by the Ninth Amended and Restated Operating Agreement, as amended (the "Operating Agreement"), which sets out the Company's governance and the respective rights of its members. This equity capital supported the development and commercialization of the Company's technology before the 2026 note financing, in connection with which the Company also issued warrants.

Dennis Doyle has served as Chief Executive Officer since October 2022 and has sat on the Company's board of directors (the "Board") since June 2024.


Operations Overview

Synexis reaches customers both directly and through distributors and resellers, a mix that gives it access to a range of industries and geographic markets. The Company's own commercial and customer-support staff manage both sets of relationships.

Products and Technology

The Company's product line lets customers deploy the same DHP technology in three ways: through a building's existing ventilation system, in individual rooms, or across larger operating spaces.

All of the devices work the same way. Airflow carries oxygen and humidity into the unit, where light activates a catalyst that converts them into DHP, which then disperses into the surrounding space. The devices are designed to run continuously in occupied environments and to act on both air and surfaces. At the core of every product is a proprietary catalyst component called a "sail," which Synexis makes in-house in Kansas. Because each installed device needs replacement sails, that in-house production links the Company's proprietary chemistry and technical know-how directly to recurring consumables demand.

Regulation and Intellectual Property

Before the devices can be marketed and sold, they must meet applicable product and electrical safety requirements. Additional testing and regulatory requirements turn on each device's intended uses and on the claims made about its effectiveness against particular microorganisms. As a result, the Company incurs continuing costs to maintain its certifications and approvals, and its research and development work extends beyond device design to the testing that supports its product claims.

Synexis has also built a portfolio of more than 100 patents and patent applications across more than 20 countries. The portfolio covers the DHP generation process, applications of the technology, and equipment and sail designs, and it requires ongoing prosecution and maintenance.

Facilities and Workforce

The Company's principal office and operating facilities are in the Kansas City area, where it leases office, laboratory, and production space. It also relies on third-party storage and logistics outside the area.

Approximately 40 employees and contractors support the business, working across finance and human resources, technology and product development, operations and quality control, sales, marketing, and customer service.

Principal Assets

The Company's principal operating assets are its intellectual property, devices and components, receivables, equipment, and interests in its subsidiaries. Inventory is by far its largest book asset. That inventory consists of finished devices, materials, and supplies and was carried at $16.4 million as of September 30, 2026, net of an inventory reserve of approximately $5.8 million. Synexis also carries an Employee Retention Credit receivable of approximately $2.75 million. The claim remains pending with the Internal Revenue Service, and the Company does not know when, or whether, it will be paid.


Prepetition Obligations

The Company's principal funded debt consists of $7.05 million in aggregate principal amount of senior secured notes (the "Notes"), issued under a Senior Secured Note Purchase Agreement dated as of March 1, 2026.

Beyond the Notes, the Company's prepetition obligations stem from ordinary operations: amounts owed to suppliers and service providers, employee compensation and benefits, leases, customer deposits, and deferred revenue. The Company estimates its ordinary-course payables at approximately $320,000.


Events Leading to Bankruptcy

Operating Losses

Building the business required heavy investment in research and development, intellectual property, regulatory compliance, inventory, and commercial expansion. According to the Company, that spending outpaced revenue, and Synexis has historically operated at a loss. It covered the gap mainly through equity investment and, more recently, through the Notes.

2026 Liquidity Decline

The Note financing left Synexis with approximately $5.8 million of cash as of April 30, 2026, after it received substantially all of the proceeds. That cushion eroded quickly. Revenue fell well below budget over the course of 2026, and several sources of cash the Company had counted on were delayed: proceeds from inventory sales, the liquidation of raw materials, and the Employee Retention Credit. Synexis sought additional financing while the credit remained unpaid. By the Petition Date, cash had dwindled to approximately $100,000, and the Company needed new financing to meet payroll and keep operating.

Prepetition Marketing Process

With liquidity tightening, the Company engaged Brown, Gibbons, Lang & Company Securities, LLC ("BGL") on August 19, 2026 to explore a sale, recapitalization, or other strategic transaction. BGL began marketing the business on September 11, 2026, and the Board ratified the engagement on September 22, 2026.


Chapter 11 Filing

Synexis filed for Chapter 11 on November 18, 2026 and elected to proceed under Subchapter V. The Company commenced the case to preserve its operating business while it completes a transaction that maximizes value for stakeholders. It intends to sell to the highest or otherwise best bidder and to pursue a plan addressing the disposition of the estate. In the meantime, its focus is on continuing to serve customers, funding necessary expenses, and providing an orderly process for its go-forward transactions and restructuring efforts.

Restructuring Committee

The groundwork for the filing was laid in the weeks before it. On October 21, 2026, Claudia Z. Springer, who has restructuring experience, joined the Board as an independent director. Five days later, on October 26, the Board formed a Restructuring Committee with Ms. Springer as its sole member and chair, and delegated to it authority over restructuring matters, including financing, a potential sale, the conduct of the Chapter 11 case, and transactions involving insiders.

At the same meeting, the Board ratified the engagement of Pack Law as lead restructuring counsel and Morris, Nichols, Arsht & Tunnell LLP as Delaware co-counsel. It also authorized the Chapter 11 filing, subject to conditions that included Ms. Springer's written recommendation and an amendment to the Operating Agreement, which took effect on October 31, 2026. Both conditions were satisfied before the Petition Date, and Ms. Springer has since led the DIP financing negotiations.

DIP Financing

The Company seeks approval of a $1.5 million DIP facility from Bryan Marsal or his designee, along with use of cash collateral, to fund operations during the sale process. The facility is conditioned on that sale process and on other obligations and protections set out in the DIP motion. According to the Company, the liquidity needed for postpetition operations, including all relief sought in the other first-day motions, depends on approval of the DIP financing, and any delay could impair its ability to retain its workforce, buy supplies, and meet customer obligations.


First Day Motions